T. Rowe Price Associates, Inc. 13D and 13G filings for IGM Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 1:22 pm Purchase | 2024-09-30 | 13G | IGM Biosciences, Inc. IGMS | T. Rowe Price Associates, Inc. | 4,014,259 11.800% | 610,545 (+17.94%) | Filing |
| 2024-02-12 10:07 am Purchase | 2024-01-31 | 13G | IGM Biosciences, Inc. IGMS | T. Rowe Price Associates, Inc. | 3,403,714 10.300% | 141,505 (+4.34%) | Filing |
| 2024-02-12 10:03 am Purchase | 2023-12-31 | 13G | IGM Biosciences, Inc. IGMS | T. Rowe Price Associates, Inc. | 3,262,209 9.900% | 1,055,802 (+47.85%) | Filing |
| 2023-02-14 12:38 pm Sale | 2022-12-31 | 13G | IGM Biosciences, Inc. IGMS | T. Rowe Price Associates, Inc. | 2,206,407 7.600% | -164,868 (-6.95%) | Filing |
| 2022-02-14 2:34 pm Purchase | 2021-12-31 | 13G | IGM Biosciences, Inc. IGMS | T. Rowe Price Associates, Inc. | 2,371,275 9.100% | 1,042,491 (+78.45%) | Filing |
| 2021-02-16 12:24 pm Purchase | 2020-12-31 | 13G | IGM Biosciences, Inc. IGMS | T. Rowe Price Associates, Inc. | 1,328,784 5.200% | 1,328,784 (New Position) | Filing |